|
|
|
|
LEADER |
02094nam a2200349 u 4500 |
001 |
EB001999857 |
003 |
EBX01000000000000001162758 |
005 |
00000000000000.0 |
007 |
tu||||||||||||||||||||| |
008 |
210907 r ||| eng |
100 |
1 |
|
|a Tsou, Amy Y.
|
245 |
0 |
0 |
|a No-touch modalities for disinfecting patient rooms in acute care settings
|h Elektronische Ressource
|c Amy Y. Tsou, Savvas Pavlides, Laura Koepfler, Coyne Drummond
|
260 |
|
|
|a Rockville, MD
|b Agency for Healthcare Research and Quality, Department of Health and Human Services, USA,
|c 2020, October 2, 2020
|
300 |
|
|
|a 1 PDF file (32 pages)
|b illustration
|
505 |
0 |
|
|a Includes bibliographical references
|
653 |
|
|
|a Virus Diseases / prevention & control
|
653 |
|
|
|a Emergency Service, Hospital
|
653 |
|
|
|a Respiratory Tract Infections / prevention & control
|
653 |
|
|
|a Disinfection
|
653 |
|
|
|a United States
|
653 |
|
|
|a Patients' Rooms
|
700 |
1 |
|
|a Pavlides, Savvas
|e [author]
|
700 |
1 |
|
|a Koepfler, Laura
|e [author]
|
700 |
1 |
|
|a Drummond, Coyne
|e [author]
|
710 |
2 |
|
|a United States
|b Agency for Healthcare Research and Quality
|
710 |
2 |
|
|a Evidence-based Practice Centers Program (U.S.)
|
041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
989 |
|
|
|b NCBI
|a National Center for Biotechnology Information
|
490 |
0 |
|
|a AHRQ Pub.
|
856 |
4 |
0 |
|u http://www.ncbi.nlm.nih.gov/books/NBK563017
|3 Volltext
|n NLM Bookshelf Books
|3 Volltext
|
082 |
0 |
|
|a 610
|
520 |
|
|
|a Since data directly assessing no-touch modalities for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are not yet readily available, we conducted a rapid review of notouch modalities for disinfecting other respiratory viral pathogens in patient rooms in hospital/acute care settings. We also included studies reporting the effect of these modalities on Clostridioides (formerly Clostridium) difficile (CD) environmental contamination or infection (CDI) rates. Since CD spores are easily transmitted to surfaces and difficult to eradicate, 9 the notouch modalities that are effective against CD spores may be effective against SARS-CoV-2
|